In a filing, Goosehead Insurance Inc revealed its Member of 10% owner group Mark & Robyn Jones Descendants unloaded Company’s shares for reported $2.94 million on Jul 31 ’25. In the deal valued at $93.24 per share,31,516 shares were sold. As a result of this transaction, Mark & Robyn Jones Descendants now holds 0 shares worth roughly $0.0.
Then, Mark E. Jones bought 300,000 shares, generating $27,435,000 in total proceeds.
Before that, Jones Mark E. Jr. bought 1,149 shares. Goosehead Insurance Inc shares valued at $98,906 were divested by the Chief Financial Officer at a price of $86.08 per share. As a result of the transaction, Jones Mark E. Jr. now holds 3,491 shares, worth roughly $0.31 million.
Piper Sandler downgraded its Goosehead Insurance Inc [GSHD] rating to a Neutral from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including BMO Capital Markets’s analysts, who decreased its forecast for the stock in late August from “an Outperform” to “a Market perform”. TD Cowen also remained covering GSHD and has decreased its forecast on August 15, 2024 with a “Hold” recommendation from previously “Buy” rating. TD Cowen started covering the stock on January 10, 2024. It rated GSHD as “an Outperform”.
Price Performance Review of GSHD
On Tuesday, Goosehead Insurance Inc [NASDAQ:GSHD] saw its stock unchanged to $88.65. Over the last five days, the stock has gained 2.19%. Goosehead Insurance Inc shares have risen nearly 7.51% since the year began. Nevertheless, the stocks have fallen -12.64% over the past one year.
How much short interest is there in Goosehead Insurance Inc?
A steep rise in short interest was recorded in Goosehead Insurance Inc stocks on 2025-07-15, growing by 0.2 million shares to a total of 2.16 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 1.97 million shares. There was a rise of 9.12%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 17, 2023 when UBS began covering the stock and recommended ‘”a Buy”‘ rating along with a $84 price target.
